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The Pacific yew tree is a fairly small and slow growing conifer native to the Pacific
Northwest. The Gila monster is a lizard with striking orange and black markings from the
drylands of the Southwestern US and Mexico. Two very different organisms, but with a
fascinating connection.
They’ve both given us drugs that have saved and improved the lives of millions of people.
Paclitaxel, originally isolated in 1971 from the bark of the Pacific Yew tree, is so important
for treating various cancers that it is one of the World Health Organisation’s “Essential 
Medicines”. This compound has been studied in more than 3,000 clinical trials. It’s safe
and effective and it generates sales of around US$80-100m per year.
Nature’s medicinal marvels
Exenatide, a synthetic version of a compound
found in the saliva of the Gila monster, is an
injected treatment used by as many as two 
million people with type 2 diabetes. In 2014,
exenatide products generated sales of US$767m.
Not only that, but exenatide has also been shown
to have potential in the treatment of Parkinson’s 
Disease.
These two examples illustrate how significantly
compounds sourced from nature can benefit
public health, but they also tell a deeper story of
how we fail to protect nature. Up until fairly
recently, paclitaxel had to be isolated from the
bark of wild Pacific yew trees, which meant stripping the bark and killing these rare and 
slow growing trees.
The Gila monster. Reptiles4all/Shutterstock
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The Pacific yew tree (Taxus brevifolia)
foliage and fruit. Jason Hollinger/Wikimedia 
Commons., CC BY
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In 1977, demand for the drug generated an order for 7,000lbs (3,175kg) of bark, which
yielded a mere 132 grams of paclitaxel. This demand destroyed 1,500 trees, damaging the
native environments in which they grow. This destruction continued until 1994 when
chemists came up with a way of synthesising paclitaxel.
The production of exenatide does not require the maceration of thousands of Gila
monsters, thankfully. However, despite the huge sums generated by the sale of the
compound, the delicate habitats where this lizard and countless other
species live are threatened by development and climate change.
The cost of environmental destruction
When it comes to discovering medicinal products found in nature, we’ve 
barely scratched the surface. With every habitat that falls to the chainsaw
or disappears under the plough or concrete, we impoverish nature and
deprive ourselves of potential medicines.
The molecular diversity of life on Earth is effectively limitless, but it is
under threat. Conservative estimates suggest that we are losing one 
important drug every two years because of our onslaught on the natural
world.
 
The Gila monster (Heloderma suspectum) at home in the
Mojave Desert, USA. Jay Pierstorff/Shutterstock
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Perversely, this onslaught comes amid a new golden age of discovery. Tools, such as DNA sequencing,
can reveal “new” species hiding in plain sight, while advances in mass spectrometry, genomics and
genetic engineering have allowed us to harness their molecular diversity without excessive harvesting
of wild specimens.
Although the potential of natural products is undisputed, the enormous amount of effort and
resources required to bring a promising molecule to market is offputting. Not only that, but
unscrupulous “bioprospectors” have illegally collected living material, often from developing 
countries. These predatory practices prompted legislation that now hinders legitimate natural
products research that seeks to protect biodiversity.
Read more: Drugs from bugs: the next blockbuster medicine could be lurking inside 
an insect
Unlocking nature’s potential
Magainin was the first anti-microbial protein discovered in an organism, isolated from the skin
secretions of the African clawed frog. The discovery stems from the observation that surgical wounds
on these frogs rarely become infected despite non-sterile procedures and conditions. Efforts to
commercialise this molecule were mired in difficulties and today, despite the promise of a potentially
transformative drug to treat infections, no magainin products are available.
Natural products give us a compelling angle for the protection of overlooked species and their
habitats, but we need an ethical and transparent approach for developing them. To some extent, this
is the goal of the Convention on Biological Diversity and the Nagoya Protocol – international
agreements on sharing the benefits derived from biodiversity fairly.
But as a result of these treaties, the academics working to find new drugs in nature must meet the
same regulatory requirements as companies with commercial intent. Extensive permitting
requirements mean many academic scientists are avoiding international collaborations to study 
biodiversity altogether – hampering the discovery of new molecules.
Nature is our most dependable resource for medical breakthroughs – but for how much longer?
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The author’s take on how humans presently exploit biodiversity. Rob Jenkins, Author provided
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Governments need to support research efforts and collaboration between scientific disciplines such as
ecology and biochemistry, with investment and infrastructure. Building trust with communities that
live where natural products are sourced is also critical.
These steps could create a system of natural product research and development with a greater
appreciation of nature’s value. Ultimately, the equal sharing of benefits derived from drug discoveries
will help conserve nature. However, the clock is ticking and with every day that passes species and
their unique chemistry are lost forever.
Nature is a public library of information waiting to be accessed. The science, technology and political
will to read this library is being ignored while destruction continues and companies hoard resources
that have been harnessed from nature for profit. We are destroying the best library in the world in
order to build a writer’s workshop, open only to the few.
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